Total Payments
$7,790
2022 Payments
$18.66
Companies
36
Transactions
409
Medicare Patients
1,314
Medicare Billing
$115,285
Payment Breakdown by Category
Food & Beverage$7,522 (96.6%)
Education$267.67 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,522 | 402 | 96.6% |
| Education | $267.67 | 7 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,651 | 79 | $0 (2021) |
| GlaxoSmithKline, LLC. | $1,489 | 77 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $972.99 | 60 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $513.92 | 32 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $444.60 | 21 | $0 (2021) |
| Insmed, Inc. | $350.26 | 14 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $320.88 | 18 | $0 (2021) |
| Genentech USA, Inc. | $303.05 | 18 | $0 (2021) |
| Novo Nordisk Inc | $289.13 | 16 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $159.91 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $18.66 | 1 | Novo Nordisk Inc ($18.66) |
| 2021 | $2,263 | 115 | GlaxoSmithKline, LLC. ($548.81) |
| 2020 | $1,205 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($355.29) |
| 2019 | $2,042 | 106 | Boehringer Ingelheim Pharmaceuticals, Inc. ($514.09) |
| 2018 | $1,339 | 76 | GlaxoSmithKline, LLC. ($285.21) |
| 2017 | $922.29 | 52 | GlaxoSmithKline, LLC. ($184.97) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes | ||||||
| 12/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: RESPIRATORY | ||||||
| 12/21/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Respiratory | ||||||
| 12/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: DIABETES | ||||||
| 12/07/2021 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2021 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: DIABETES | ||||||
| 10/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/27/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: VACCINES | ||||||
| 10/20/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 10/19/2021 | Genentech USA, Inc. | Xolair (Biological), Actemra, Esbriet | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Immunology | ||||||
| 10/14/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2021 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Immunology | ||||||
| 10/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 12 | 617 | 788 | $273,466 | $61,992 |
| 2020 | 17 | 697 | 861 | $248,374 | $53,293 |
Total Patients
1,314
Total Services
1,649
Medicare Billing
$115,285
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 85 | 113 | $74,650 | $17,268 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 132 | $64,660 | $14,596 | 22.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 118 | $39,560 | $8,720 | 22.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 41 | 41 | $34,030 | $8,220 | 24.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 41 | $15,990 | $3,934 | 24.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 52 | 65 | $11,700 | $2,343 | 20.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 59 | 64 | $10,880 | $1,818 | 16.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $7,260 | $1,782 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 20 | $5,800 | $1,203 | 20.7% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 36 | 36 | $2,196 | $1,021 | 46.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 38 | $4,560 | $759.62 | 16.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 87 | 109 | $2,180 | $327.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 142 | $61,010 | $11,699 | 19.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 48 | 48 | $39,740 | $9,015 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 99 | 126 | $37,800 | $7,083 | 18.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 34 | 46 | $23,460 | $5,555 | 23.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 35 | $13,020 | $3,231 | 24.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 63 | 81 | $14,580 | $3,007 | 20.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 41 | $11,890 | $2,705 | 22.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $11,220 | $2,565 | 22.9% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 11 | 11 | $5,972 | $2,492 | 41.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 70 | 73 | $11,930 | $2,270 | 19.0% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 42 | 42 | $2,562 | $1,162 | 45.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 46 | 46 | $5,520 | $890.17 | 16.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 16 | $2,560 | $586.96 | 22.9% |
About Dr. Manuel Cabrera, MD
Dr. Manuel Cabrera, MD is a Pulmonary Disease healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932271327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Cabrera, MD has received a total of $7,790 in payments from pharmaceutical and medical device companies, with $18.66 received in 2022. These payments were reported across 409 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,522).
As a Medicare-enrolled provider, Cabrera has provided services to 1,314 Medicare beneficiaries, totaling 1,649 services with total Medicare billing of $115,285. Data is available for 2 years (2020–2021), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Bronx, NY
- Active Since 11/14/2006
- Last Updated 07/09/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932271327
Products in Payments
- OFEV (Drug) $841.28
- TRELEGY ELLIPTA (Drug) $439.40
- XARELTO (Drug) $428.15
- NUCALA (Biological) $427.99
- STIOLTO RESPIMAT (Drug) $366.94
- Arikayce (Drug) $350.26
- FASENRA (Drug) $307.18
- XOLAIR (Biological) $298.31
- SYMBICORT (Drug) $270.40
- JARDIANCE (Drug) $268.33
- ANORO (Drug) $255.18
- XIFAXAN (Drug) $242.35
- ANORO ELLIPTA (Drug) $225.03
- Xolair (Biological) $217.34
- ENTRESTO (Drug) $215.61
- FASENRA (Biological) $198.88
- DUPIXENT (Biological) $160.20
- XIFAXANIBSD (Drug) $137.42
- BREO (Drug) $121.99
- Victoza (Drug) $117.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Bronx
Dr. Raji Ayinla, M.d, M.D
Pulmonary Disease — Payments: $699,684
Pulmonary Disease $699,684
Peter Dicpinigaitis, Md, MD
Pulmonary Disease — Payments: $305,607
Pulmonary Disease $305,607
Neomi Shah, M.d, M.D
Pulmonary Disease — Payments: $16,397
Pulmonary Disease $16,397
Richard Deluca, M.d, M.D
Pulmonary Disease — Payments: $14,463
Pulmonary Disease $14,463
Dr. Samuel Deleon, M.d, M.D
Pulmonary Disease — Payments: $11,703
Pulmonary Disease $11,703
Philip Klapper, Md, MD
Pulmonary Disease — Payments: $6,320
Pulmonary Disease $6,320